The latest price target for Generation Bio (NASDAQ:GBIO) was reported by Needham on May 8, 2025. The analyst firm set a price target for $8.00 expecting GBIO to rise to within 12 months (a possible 2061.58% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Generation Bio (NASDAQ:GBIO) was provided by Needham, and Generation Bio reiterated their buy rating.

There is no last upgrade for Generation Bio

The last downgrade for Generation Bio Co happened on October 23, 2023 when JMP Securities changed their price target from N/A to N/A for Generation Bio Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Generation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Generation Bio was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.

While ratings are subjective and will change, the latest Generation Bio (GBIO) rating was a reiterated with a price target of $8.00 to $8.00. The current price Generation Bio (GBIO) is trading at is $0.37, which is out of the analyst’s predicted range.